The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Defining the Roles of TcdA and TcdB in Localized Gastrointestinal Disease, Systemic Organ Damage, and the Host Response during Clostridium difficile Infections
Open accessAbstract
Clostridium difficile is a leading cause of antibiotic-associated diarrhea, a significant animal pathogen, and a worldwide public health burden. Most disease-causing strains secrete two exotoxins, TcdA and TcdB, which are considered to be the primary virulence factors. Understanding the role that these toxins play in disease is essential for the rational design of urgently needed new therapeutics. However, their relative contributions to disease remain contentious. Using three different animal models, we show that TcdA + TcdB − mutants are attenuated in virulence in comparison to the wild-type (TcdA + TcdB + ) strain, whereas TcdA − TcdB + mutants are fully virulent. We also show for the first time that TcdB alone is associated with both severe localized intestinal damage and systemic organ damage, suggesting that this toxin might be responsible for the onset of multiple organ dysfunction syndrome (MODS), a poorly characterized but often fatal complication of C. difficile infection (CDI). Finally, we show that TcdB is the primary factor responsible for inducing the in vivo host innate immune and inflammatory responses. Surprisingly, the animal infection model used was found to profoundly influence disease outcomes, a finding which has important ramifications for the validation of new therapeutics and future disease pathogenesis studies. Overall, our results show unequivocally that TcdB is the major virulence factor of C. difficile and provide new insights into the host response to C. difficile during infection. The results also highlight the critical nature of using appropriate and, when possible, multiple animal infection models when studying bacterial virulence mechanisms. IMPORTANCE Clostridium difficile is a leading cause of antibiotic-associated diarrhea and an important hospital pathogen. TcdA and TcdB are thought to be the primary virulence factors responsible for disease symptoms of C. difficile infections (CDI). However, the individual contributions of these toxins to disease remain contentious. Using three different animal models of infection, we show for the first time that TcdB alone causes severe damage to the gut, as well as systemic organ damage, suggesting that this toxin might be responsible for MODS, a serious but poorly understood complication of CDI. These findings provide important new insights into the host response to C. difficile during infection and should guide the rational development of urgently required nonantibiotic therapeutics for the treatment of CDI.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
Brenchley, J. M., Price, D. A., Schacker, T. W., Asher, T. E., Silvestri, G., Rao, S., Kazzaz, Z., Bornstein, E., Lambotte, O., Altmann, D., et al. (2006) · Nature Medicine · doi:10.1038/nm1511 · Cited by 3,559
Okayasu, I., Hatakeyama, S., Yamada, M., Ohkusa, T., Inagaki, Y., & Nakaya, R. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)90290-h · Cited by 2,401
Cytochrome P450 and Chemical Toxicology
Guengerich, F. P. (2008) · Chemical Research in Toxicology · doi:10.1021/tx700079z · Cited by 1,725
Hediger, M. A., Romero, M. F., Peng, J.-B., Rolfs, A., Takanaga, H., & Bruford, E. A. (2004) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/s00424-003-1192-y · Cited by 985
The role of toxin A and toxin B in Clostridium difficile infection
Kuehne, S. A., Cartman, S. T., Heap, J. T., Kelly, M. L., Cockayne, A., & Minton, N. P. (2010) · Nature · doi:10.1038/nature09397 · Cited by 855
The Changing Epidemiology of Clostridium difficile Infections
Freeman, J., Bauer, M. P., Baines, S. D., Corver, J., Fawley, W. N., Goorhuis, B., Kuijper, E. J., & Wilcox, M. H. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00082-09 · Cited by 826
Toxin B is essential for virulence of Clostridium difficile
Lyras, D., O’Connor, J. R., Howarth, P. M., Sambol, S. P., Carter, G. P., Phumoonna, T., Poon, R., Adams, V., Vedantam, G., Johnson, S., et al. (2009) · Nature · doi:10.1038/nature07822 · Cited by 745
Self-citationThe UDP-glucuronosyltransferases: Their role in drug metabolism and detoxification
Rowland, A., Miners, J. O., & Mackenzie, P. I. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.02.019 · Cited by 709
Diverse Sources of C. difficile Infection Identified on Whole-Genome Sequencing
Eyre, D. W., Cule, M. L., Wilson, D. J., Griffiths, D., Vaughan, A., O'Connor, L., Ip, C. L. C., Golubchik, T., Batty, E. M., Finney, J. M., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1216064 · Cited by 648
A mouse model of clostridium difficile-associated disease
Chen, X., Katchar, K., Goldsmith, J. D., Nanthakumar, N., Cheknis, A., Gerding, D. N., & Kelly, C. P. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.09.002 · Cited by 510 · cited 1×
“First, an optimized mouse infection model, based on a previously published model (14) and further developed at Monash University (Australia), in which animals consistently develop severe disease was used.”
MethodSelf-citationClostridium difficile binary toxin CDT: Mechanism, epidemiology, and potential clinical importance
Gerding, D. N., Johnson, S., Rupnik, M., & Aktories, K. (2014) · Gut Microbes · doi:10.4161/gmic.26854 · Cited by 416
Self-citationLawley, T. D., Clare, S., Walker, A. W., Goulding, D., Stabler, R. A., Croucher, N., Mastroeni, P., Scott, P., Raisen, C., Mottram, L., et al. (2009) · Infection and Immunity · doi:10.1128/iai.00558-09 · Cited by 349
Self-citationSchwan, C., Stecher, B., Tzivelekidis, T., van Ham, M., Rohde, M., Hardt, W.-D., Wehland, J., & Aktories, K. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000626 · Cited by 337
Clostridium difficile infection in the community: a zoonotic disease?
Hensgens, M. P. M., Keessen, E. C., Squire, M. M., Riley, T. V., Koene, M. G. J., de Boer, E., Lipman, L. J. A., & Kuijper, E. J. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03853.x · Cited by 290
Bacterial protein toxins that modify host regulatory GTPases
Aktories, K. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2592 · Cited by 288
Oxidative stress in inflammation‐based gastrointestinal tract diseases: Challenges and opportunities
Kim, Y. J., Kim, E., & Hahm, K. B. (2012) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2012.07108.x · Cited by 242
Clostridium difficile toxin B is an inflammatory enterotoxin in human intestine
Savidge, T. C., Pan, W.-H., Newman, P., O’Brien, M., Anton, P. M., & Pothoulakis, C. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00902-8 · Cited by 230
Importance of Toxin A, Toxin B, and CDT in Virulence of an Epidemic Clostridium difficile Strain
Kuehne, S. A., Collery, M. M., Kelly, M. L., Cartman, S. T., Cockayne, A., & Minton, N. P. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit426 · Cited by 221
Geric, B., Carman, R. J., Rupnik, M., Genheimer, C. W., Sambol, S. P., Lyerly, D. M., Gerding, D. N., & Johnson, S. (2006) · The Journal of Infectious Diseases · doi:10.1086/501368 · Cited by 196
Self-citationToxin A-negative, toxin B-positive Clostridium difficile
Drudy, D., Fanning, S., & Kyne, L. (2007) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2006.04.003 · Cited by 192
Sasaki, M., & Joh, T. (2007) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.40.1 · Cited by 171
Carter, G. P., Lyras, D., Allen, D. L., Mackin, K. E., Howarth, P. M., O’Connor, J. R., & Rood, J. I. (2007) · Journal of Bacteriology · doi:10.1128/jb.00731-07 · Cited by 171
Self-citationConstruction and analysis of chromosomal Clostridium difficile mutants
O'Connor, J. R., Lyras, D., Farrow, K. A., Adams, V., Powell, D. R., Hinds, J., Cheung, J. K., & Rood, J. I. (2006) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05315.x · Cited by 158
Self-citationLim, S. K., Stuart, R. L., Mackin, K. E., Carter, G. P., Kotsanas, D., Francis, M. J., Easton, M., Dimovski, K., Elliott, B., Riley, T. V., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu203 · Cited by 140
Self-citationFarrow, M. A., Chumbler, N. M., Lapierre, L. A., Franklin, J. L., Rutherford, S. A., Goldenring, J. R., & Lacy, D. B. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1313658110 · Cited by 135
Steele, J., Mukherjee, J., Parry, N. M., & Tzipori, S. R. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis669 · Cited by 111
Characterization of toxins A and B of Clostridium difficile with monoclonal antibodies
Lyerly, D. M., Phelps, C., Toth, J., & Wilkins, T. D. (1986) · Infection and Immunity · doi:10.1128/iai.54.1.70-76.1986 · Cited by 109
NOX2 As a Target for Drug Development: Indications, Possible Complications, and Progress
Diebold, B. A., Smith, S. M., Yang, L., & Lambeth, J. D. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.5862 · Cited by 105
Dobson, G., Hickey, C., & Trinder, J. (2003) · Intensive Care Medicine · doi:10.1007/s00134-003-1754-7 · Cited by 101
Grasberger, H., Zaatari, M. E., Dang, D. T., & Merchant, J. L. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.07.011 · Cited by 101
Steele, J., Chen, K., Sun, X., Zhang, Y., Wang, H., Tzipori, S. R., & Feng, H. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir748 · Cited by 96
Hamm, E. E., Voth, D. E., & Ballard, J. D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604725103 · Cited by 92
Vardakas, K. Z., Konstantelias, A. A., Loizidis, G., Rafailidis, P. I., & Falagas, M. E. (2012) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2012.07.010 · Cited by 76
TcsL Is an Essential Virulence Factor inClostridium sordelliiATCC 9714
Carter, G. P., Awad, M. M., Hao, Y., Thelen, T. D., Bergin, I. L., Howarth, P. M., Seemann, T., Rood, J. I., Aronoff, D. M., & Lyras, D. (2011) · Infection and Immunity · doi:10.1128/iai.00968-10 · Cited by 58
Self-citationD’Auria, K. M., Kolling, G. L., Donato, G. M., Warren, C. A., Gray, M. C., Hewlett, E. L., & Papin, J. A. (2013) · Infection and Immunity · doi:10.1128/iai.00869-13 · Cited by 57
Thymic Involution: Where Endocrinology Meets Immunology
Calder, A. E., Hince, M. N., Dudakov, J. A., Chidgey, A. P., & Boyd, R. L. (2011) · NeuroImmunoModulation · doi:10.1159/000329496 · Cited by 55
Hirota, S. A., Iablokov, V., Tulk, S. E., Schenck, L. P., Becker, H. M., Nguyen, J., Bashir, S. M. A., Dingle, T. C., Laing, A., Liu, P. J., et al. (2012) · Infection and Immunity · doi:10.1128/iai.00933-12 · Cited by 55
The gut microbiota: challenging immunology
Gill, N., & Finlay, B. B. (2011) · Nature reviews. Immunology · doi:10.1038/nri3061 · Cited by 53
Harrison, I. P., & Selemidis, S. (2014) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12238 · Cited by 47
Oxygen Radicals: Their Role in Selected Gastrointestinal Disorders
Otamiri, T., & Sjödahl, R. I. (2008) · Digestive Diseases · doi:10.1159/000171299 · Cited by 46
Prevalence of Gastrointestinal Clostridium difficile Carriage in Australian Sheep and Lambs
Knight, D. R., & Riley, T. V. (2013) · Applied and Environmental Microbiology · doi:10.1128/aem.01888-13 · Cited by 45
Novel Molecular Type ofClostridium difficilein Neonatal Pigs, Western Australia
Squire, M. M., Carter, G. P., Mackin, K. E., Chakravorty, A., Norén, T., Elliott, B., Lyras, D., & Riley, T. V. (2013) · Emerging infectious diseases · doi:10.3201/eid1905.121062 · Cited by 43
Self-citationCritical Roles of Clostridium difficile Toxin B Enzymatic Activities in Pathogenesis
Li, S., Shi, L., Yang, Z., Zhang, Y., Pérez‐Cordón, G., Huang, T., Ramsey, J. P., Oezguen, N., Savidge, T., & Feng, H. (2014) · Infection and Immunity · doi:10.1128/iai.02316-14 · Cited by 35
Zhuang, X., Wei, X., Tan, Y. L., Xiao, W., Yang, H., Xie, J., Lu, C., & Li, H. (2014) · Toxicological Sciences · doi:10.1093/toxsci/kfu067 · Cited by 35
Ballard, J. D. (2010) · Nature · doi:10.1038/467665a · Cited by 16
Cited by
Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection
Wilcox, M. H., Gerding, D. N., Poxton, I. R., Kelly, C., Nathan, R., Birch, T., Cornely, O. A., Rahav, G., Bouza, E., Lee, C., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1602615 · Cited by 858
Self-citationClostridium difficile infection
Smits, W. K., Lyras, D., Lacy, D. B., Wilcox, M. H., & Kuijper, E. J. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.20 · Cited by 853
Self-citationACG Clinical Guidelines: Prevention, Diagnosis, and Treatment of Clostridioides difficile Infections
Kelly, C. R., Fischer, M., Allegretti, J. R., LaPlante, K., Stewart, D. B., Limketkai, B. N., & Stollman, N. H. (2021) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001278 · Cited by 579
Clostridium difficile colitis: pathogenesis and host defence
Abt, M. C., McKenney, P. T., & Pamer, E. G. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.108 · Cited by 551
The role of toxins in Clostridium difficile infection
Chandrasekaran, R., & Lacy, D. B. (2017) · FEMS Microbiology Reviews · doi:10.1093/femsre/fux048 · Cited by 353
Metadata
- Authors
- Carter, G. P., Chakravorty, A., Pham Nguyen, T. A., Mileto, S., Schreiber, F., Li, L., Howarth, P., Clare, S., Cunningham, B., Sambol, S. P., Cheknis, A., Figueroa, I., Johnson, S., Gerding, D., Rood, J. I., Dougan, G., Lawley, T. D., & Lyras, D.
- Venue
- mBio
- Publisher
- American Society for Microbiology
- Published
- 2015-07
- Volume
- 6
- Issue
- 3
- Pages
- e00551-e00551
- ISSN
- 2150-7511 (ISSN-L)
- 2161-2129
- OpenAlex
- W2123458607
- Cited by
- 324
- References
- 45
- FWCI
- 24.57
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.